FHIR © HL7.org | Server Home | FHIR Server FHIR Server 3.7.21 | FHIR Version n/a User: [n/a]

703128001: Bosutinib (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Substance with enzyme inhibitor mechanism of action\Substance with transferase inhibitor mechanism of action\Substance with phosphotransferase inhibitor mechanism of action\Substance with protein kinase inhibitor mechanism of action\Substance with protein-tyrosine kinase inhibitor mechanism of action\Bosutinib

\Drug or medicament\Antineoplastic agent\Bosutinib
\Drug or medicament\Quinoline\Aminoquinoline\Bosutinib

\Substance categorized by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound\Nitrogen compound\Organic nitrogen compound\...

\Amine and/or amine derivative\Quinoline\Aminoquinoline\Bosutinib

\Nitrile\Bosutinib

\Organic compound\Organic cyclic compound\Heterocyclic compound\Quinoline\Aminoquinoline\Bosutinib
\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Quinoline\Aminoquinoline\Bosutinib
\Organic compound\Organic nitrogen compound\Nitrile\Bosutinib
\Organic compound\Organic chloride compound\Chlorinated hydrocarbon\Dichlorobenzene\Bosutinib
\Organic compound\Hydrocarbon\Halogenated hydrocarbon\Chlorinated hydrocarbon\Dichlorobenzene\Bosutinib

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2014. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

3007236019 Bosutinib (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

3007295017 Bosutinib en Synonym Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Bosutinib	Is a	Substance with protein-tyrosine kinase inhibitor mechanism of action	true	Inferred relationship	Existential restriction modifier
Bosutinib	Has disposition	Protein-tyrosine kinase inhibitor	true	Inferred relationship	Existential restriction modifier
Bosutinib	Is a	Chemical categorized functionally	false	Inferred relationship	Existential restriction modifier
Bosutinib	Is a	Substance with enzyme inhibitor mechanism of action	false	Inferred relationship	Existential restriction modifier
Bosutinib	Is a	Dichlorobenzene	true	Inferred relationship	Existential restriction modifier
Bosutinib	Is a	Nitrile	true	Inferred relationship	Existential restriction modifier
Bosutinib	Is a	Aminoquinoline	true	Inferred relationship	Existential restriction modifier
Bosutinib	Is a	Antineoplastic agent	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Bosutinib monohydrate	Is a	False	Bosutinib	Inferred relationship	Existential restriction modifier
Product containing bosutinib	Has active ingredient	True	Bosutinib	Inferred relationship	Existential restriction modifier	1
Product containing bosutinib in oral dose form (medicinal product form)	Has active ingredient	True	Bosutinib	Inferred relationship	Existential restriction modifier	1
Bosutinib monohydrate	Is modification of	True	Bosutinib	Inferred relationship	Existential restriction modifier
Bosutinib	Has active ingredient	True	Bosutinib	Inferred relationship	Existential restriction modifier	1
Product containing only bosutinib in oral dose form (medicinal product form)	Has active ingredient	True	Bosutinib	Inferred relationship	Existential restriction modifier	1
Product containing precisely bosutinib (as bosutinib monohydrate) 100 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance	False	Bosutinib	Inferred relationship	Existential restriction modifier	1
Product containing precisely bosutinib (as bosutinib monohydrate) 500 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance	False	Bosutinib	Inferred relationship	Existential restriction modifier	1
Product containing precisely bosutinib 100 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance	True	Bosutinib	Inferred relationship	Existential restriction modifier	1
Product containing precisely bosutinib 100 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Bosutinib	Inferred relationship	Existential restriction modifier	1
Product containing precisely bosutinib 500 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance	True	Bosutinib	Inferred relationship	Existential restriction modifier	1
Product containing precisely bosutinib 400 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance	True	Bosutinib	Inferred relationship	Existential restriction modifier	1
Product containing precisely bosutinib 400 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Bosutinib	Inferred relationship	Existential restriction modifier	1
Product containing precisely bosutinib 500 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Bosutinib	Inferred relationship	Existential restriction modifier	1
Product containing precisely bosutinib monohydrate 100 milligram/1 each conventional release oral tablet	Has active ingredient	False	Bosutinib	Inferred relationship	Existential restriction modifier
Product containing precisely bosutinib monohydrate 500 milligram/1 each conventional release oral tablet	Has active ingredient	False	Bosutinib	Inferred relationship	Existential restriction modifier
Bosutinib 100mg tablets	Has specific active ingredient	True	Bosutinib	Inferred relationship	Existential restriction modifier
Bosutinib 500mg tablets	Has specific active ingredient	True	Bosutinib	Inferred relationship	Existential restriction modifier
Bosutinib 100mg tablets	Has specific active ingredient	False	Bosutinib	Inferred relationship	Existential restriction modifier
Bosutinib 500mg tablets	Has specific active ingredient	False	Bosutinib	Inferred relationship	Existential restriction modifier
Bosutinib 500mg tablets 28 tablet	Has specific active ingredient	True	Bosutinib	Inferred relationship	Existential restriction modifier
Bosutinib 100mg tablets 28 tablet	Has specific active ingredient	True	Bosutinib	Inferred relationship	Existential restriction modifier
Bosulif 100mg tablets (Pfizer Ltd)	Has specific active ingredient	True	Bosutinib	Inferred relationship	Existential restriction modifier
Bosulif 500mg tablets (Pfizer Ltd)	Has specific active ingredient	True	Bosutinib	Inferred relationship	Existential restriction modifier
Bosutinib 100mg tablets	Has specific active ingredient	False	Bosutinib	Inferred relationship	Existential restriction modifier
Bosutinib 500mg tablets	Has specific active ingredient	False	Bosutinib	Inferred relationship	Existential restriction modifier
Bosulif 100mg tablets (Pfizer Ltd) 28 tablet 2 x 14 tablets	Has specific active ingredient	True	Bosutinib	Inferred relationship	Existential restriction modifier
Bosulif 500mg tablets (Pfizer Ltd) 28 tablet 2 x 14 tablets	Has specific active ingredient	True	Bosutinib	Inferred relationship	Existential restriction modifier
Bosutinib 100mg tablets	Has active ingredient	False	Bosutinib	Inferred relationship	Existential restriction modifier
Bosutinib 500mg tablets	Has active ingredient	False	Bosutinib	Inferred relationship	Existential restriction modifier
Bosulif 100mg tablets (Pfizer Ltd)	Has active ingredient	False	Bosutinib	Inferred relationship	Existential restriction modifier
Bosulif 500mg tablets (Pfizer Ltd)	Has active ingredient	False	Bosutinib	Inferred relationship	Existential restriction modifier
Product containing precisely bosutinib monohydrate 500 milligram/1 each conventional release oral tablet	Has specific active ingredient	False	Bosutinib	Inferred relationship	Existential restriction modifier
Product containing precisely bosutinib monohydrate 100 milligram/1 each conventional release oral tablet	Has specific active ingredient	False	Bosutinib	Inferred relationship	Existential restriction modifier
Bosutinib 400mg tablets	Has active ingredient	False	Bosutinib	Inferred relationship	Existential restriction modifier
Bosutinib 400mg tablets	Has specific active ingredient	True	Bosutinib	Inferred relationship	Existential restriction modifier
Bosulif 400mg tablets (Pfizer Ltd)	Has active ingredient	True	Bosutinib	Inferred relationship	Existential restriction modifier
Bosulif 400mg tablets (Pfizer Ltd)	Has specific active ingredient	True	Bosutinib	Inferred relationship	Existential restriction modifier
Bosutinib 400mg tablets 28 tablet	Has specific active ingredient	True	Bosutinib	Inferred relationship	Existential restriction modifier
Bosulif 400mg tablets (Pfizer Ltd) 28 tablet 2 x 14 tablets	Has specific active ingredient	True	Bosutinib	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3007236019	Bosutinib (substance)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
3007295017	Bosutinib	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module